Journey Advisory Group’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-3,875
Closed -$398K – 234
2022
Q4
$398K Sell
3,875
-75
-2% -$8.64K 0.1% 152
2022
Q3
$419K Hold
3,950
– – 0.11% 158
2022
Q2
$455K Sell
3,950
-300
-7% -$29.7K 0.1% 161
2022
Q1
$443K Hold
4,250
– – 0.11% 148
2021
Q4
$520K Hold
4,250
– – 0.14% 128
2021
Q3
$488K Hold
4,250
– – 0.16% 115
2021
Q2
$412K Hold
4,250
– – 0.13% 130
2021
Q1
$313K Hold
4,250
– – 0.11% 147
2020
Q4
$290K Buy
+4,250
New +$277K 0.11% 142

Other funds holding AMN

Journey Advisory Group's AMN Position: Q1 2023 in Review

Journey Advisory Group sold out of AMN Healthcare (AMN) in Q1 2023, closing a stake of 3,875 shares — an estimated $398K sold.

Journey Advisory Group first reported a position in AMN in Q4 2020 and held it in 9 quarters. The position peaked at $520K in Q4 2021. 453 funds tracked by Wall St. Rank hold AMN as of Q1 2023.

  • Journey Advisory Group reported no remaining AMN Healthcare position as of Q1 2023 after selling out during the quarter.
  • Journey Advisory Group sold 3,875 AMN Healthcare shares in Q1 2023, an estimated $398K.
  • Journey Advisory Group first reported a position in AMN Healthcare in Q4 2020 and held it in 9 quarters.
  • Journey Advisory Group's AMN Healthcare position peaked at $520K in Q4 2021.
  • 453 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2023.

Based on Journey Advisory Group's 13F filing for Q1 2023, filed 4 May 2023.